AJP - Renal Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 295: F1222-F1229, 2008. First published August 20, 2008; doi:10.1152/ajprenal.00081.2008
0363-6127/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/4/F1222    most recent
00081.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaillard, V.
Right arrow Articles by Lartaud, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaillard, V.
Right arrow Articles by Lartaud, I.

Renal function and structure in a rat model of arterial calcification and increased pulse pressure

Virginie Gaillard,2 Bernard Jover,2 Daniel Casellas,2 Magali Cordaillat,1 Jeffrey Atkinson,1 and Isabelle Lartaud1

1Cardiovascular Pharmacology Laboratory, Pharmacy Faculty, Nancy University, Nancy; and 2Groupe Rein et Hypertension, Institut Universitaire de Recherche Clinique, Montpellier I University, Montpellier, France

Submitted 15 February 2008 ; accepted in final form 18 August 2008

Clinical studies suggest a strong link between tissue calcification and pressure hyperpulsatility in end stage renal disease patients. Using a Wistar rat model of arterial elastocalcinosis and hyperpulsatility [vitamin D and nicotine (VDN) treatment], we evaluated the relative importance of tissue calcification and hyperpulsatility in the etiology of renal failure. VDN rats showed significant increases in aortic wall calcium content (50 times; 992 ± 171 vs. control 19 ± 1 µmol/g dry wt) and pulse pressure (1.5 times; 61 ± 4 vs. control 40 ± 2 mmHg). Significant renal calcification (16 times; 124 ± 27 vs. control 8.1 ± 0.7 µmol/g dry wt) occurred mainly within the media of the preglomerular vasculature and in the areas of interstitial fibrosis in VDN. Extensive renal damages (5 times; 26 ± 5% of collapsed-atrophic or sclerotic glomeruli, or glomerular cysts vs. control 5.2 ± 0.3%; 28 times; 61 ± 12% areas of focal, cortical areas exhibiting interstitial fibrosis per section vs. control 2.2 ± 0.6%) were observed histologically. The glomerular filtration rate significantly decreased (880 ± 40 vs. control 1,058 ± 44 µl·min–1·g kidney wt–1). Albuminuria increased six times (1.6 ± 0.4 vs. control 0.27 ± 0.04 mg/24 h). There were significant linear relationships between albuminuria and pulse pressure (r2 = 0.408; n = 24) or renal calcium content (r2 = 0.328; n = 24; P < 0.05) and between glomerular filtration rate and pulse pressure (r2 = 0.168; n = 27). To our knowledge, this study provides the first evidence of links between both 1) hyperpulsatility and renal dysfunction, and 2) renal calcification and renal dysfunction. Given the increasing frequency of end-stage renal disease, this model could prove useful for preclinical evaluation of drugs that prevent or attenuate hyperpulsatility and/or tissue calcification.

pulse pressure; renal failure; albuminuria; renal histology



Address for reprint requests and other correspondence: J. Atkinson, Pharmacology Laboratory, Pharmacy Faculty, Nancy Univ., 5 rue Albert Lebrun, 54 000 Nancy, France (e-mail: Jeffrey.Atkinson{at}pharma.uhp-nancy.fr)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.